BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 7552798)

  • 1. Natural history of trisomy 21 fetuses with increased nuchal translucency thickness.
    Pandya PP; Snijders RJ; Johnson S; Nicolaides KH
    Ultrasound Obstet Gynecol; 1995 Jun; 5(6):381-3. PubMed ID: 7552798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrauterine lethality of trisomy 21 fetuses with increased nuchal translucency thickness.
    Hyett JA; Sebire NJ; Snijders RJ; Nicolaides KH
    Ultrasound Obstet Gynecol; 1996 Feb; 7(2):101-3. PubMed ID: 8776233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fetal nuchal translucency: ultrasound screening for fetal trisomy in the first trimester of pregnancy.
    Nicolaides KH; Brizot ML; Snijders RJ
    Br J Obstet Gynaecol; 1994 Sep; 101(9):782-6. PubMed ID: 7947527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First-trimester fetal nuchal translucency thickness and risk for trisomies.
    Pandya PP; Brizot ML; Kuhn P; Snijders RJ; Nicolaides KH
    Obstet Gynecol; 1994 Sep; 84(3):420-3. PubMed ID: 8058241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for Down's syndrome by fetal nuchal translucency measurement in a general obstetric population.
    Pajkrt E; van Lith JM; Mol BW; Bleker OP; Bilardo CM
    Ultrasound Obstet Gynecol; 1998 Sep; 12(3):163-9. PubMed ID: 9793187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of first-trimester nuchal translucency on second-trimester maternal serum biochemical screening for Down's syndrome.
    Thilaganathan B; Slack A; Wathen NC
    Ultrasound Obstet Gynecol; 1997 Oct; 10(4):261-4. PubMed ID: 9383877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased nuchal translucency as a marker for fetal chromosomal defects.
    Taipale P; Hiilesmaa V; Salonen R; Ylöstalo P
    N Engl J Med; 1997 Dec; 337(23):1654-8. PubMed ID: 9385124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The implementation of first-trimester scanning at 10-13 weeks' gestation and the measurement of fetal nuchal translucency thickness in two maternity units.
    Pandya PP; Goldberg H; Walton B; Riddle A; Shelley S; Snijders RJ; Nicolaides KH
    Ultrasound Obstet Gynecol; 1995 Jan; 5(1):20-5. PubMed ID: 7850584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuchal translucency thickness and crown-rump length in twin pregnancies with chromosomally abnormal fetuses.
    Pandya PP; Hilbert F; Snijders RJ; Nicolaides KH
    J Ultrasound Med; 1995 Aug; 14(8):565-8. PubMed ID: 7474052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defects and syndromes in chromosomally normal fetuses with increased nuchal translucency thickness at 10-14 weeks of gestation.
    Souka AP; Snijders RJ; Novakov A; Soares W; Nicolaides KH
    Ultrasound Obstet Gynecol; 1998 Jun; 11(6):391-400. PubMed ID: 9674084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for Down's syndrome by fetal nuchal translucency measurement in a high-risk population.
    Pajkrt E; Mol BW; van Lith JM; Bleker OP; Bilardo CM
    Ultrasound Obstet Gynecol; 1998 Sep; 12(3):156-62. PubMed ID: 9793186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First-trimester nuchal translucency and cardiac septal defects in fetuses with trisomy 21.
    Hyett JA; Moscoso G; Nicolaides KH
    Am J Obstet Gynecol; 1995 May; 172(5):1411-3. PubMed ID: 7755046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group.
    Snijders RJ; Noble P; Sebire N; Souka A; Nicolaides KH
    Lancet; 1998 Aug; 352(9125):343-6. PubMed ID: 9717920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of first-trimester screening by fetal nuchal translucency and maternal age.
    Theodoropoulos P; Lolis D; Papageorgiou C; Papaioannou S; Plachouras N; Makrydimas G
    Prenat Diagn; 1998 Feb; 18(2):133-7. PubMed ID: 9516014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for fetal trisomy 21 in the first trimester of pregnancy: maternal serum free beta-hCG and fetal nuchal translucency thickness.
    Noble PL; Abraha HD; Snijders RJ; Sherwood R; Nicolaides KH
    Ultrasound Obstet Gynecol; 1995 Dec; 6(6):390-5. PubMed ID: 8903913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for chromosomal abnormalities in an unselected population by fetal nuchal translucency.
    Hafner E; Schuchter K; Philipp K
    Ultrasound Obstet Gynecol; 1995 Nov; 6(5):330-3. PubMed ID: 8590203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosomal defects and outcome in 1015 fetuses with increased nuchal translucency.
    Pandya PP; Kondylios A; Hilbert L; Snijders RJ; Nicolaides KH
    Ultrasound Obstet Gynecol; 1995 Jan; 5(1):15-9. PubMed ID: 7850583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal serum hCG and fetal nuchal translucency thickness for the prediction of fetal trisomies in the first trimester of pregnancy.
    Brizot ML; Snijders RJ; Butler J; Bersinger NA; Nicolaides KH
    Br J Obstet Gynaecol; 1995 Feb; 102(2):127-32. PubMed ID: 7538782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for trisomy 21 in twin pregnancies by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation.
    Sebire NJ; Snijders RJ; Hughes K; Sepulveda W; Nicolaides KH
    Br J Obstet Gynaecol; 1996 Oct; 103(10):999-1003. PubMed ID: 8863698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fetal karyotyping in twin pregnancies: selection of technique by measurement of fetal nuchal translucency.
    Sebire NJ; Noble PL; Psarra A; Papapanagiotou G; Nicolaides KH
    Br J Obstet Gynaecol; 1996 Sep; 103(9):887-90. PubMed ID: 8813308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.